Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4883

Introduced
7/25/23  
Refer
7/25/23  

Caption

Medicare Common Ownership Transparency Act of 2023

Impact

The implementation of HB 4883 is set to have significant implications for state laws surrounding healthcare and pharmacy operations. Specifically, it will formalize the requirement for healthcare organizations to disclose ownership details, which could lead to scrutiny over how these entities influence pricing and access within the Medicare program. By requiring evaluation of integrated operations within the Medicare framework every three years, the legislation is positioned to inform Congress on the state of vertical integration, enhancing legislative oversight of the healthcare industry.

Summary

House Bill 4883, titled the 'Medicare Common Ownership Transparency Act of 2023,' aims to amend the Social Security Act to enhance the transparency of ownership information related to healthcare providers and pharmacies. The bill mandates that Medicare Advantage organizations and certain pharmacy benefit managers must disclose specific ownership details to the Secretary at designated intervals. This transparency is expected to improve accountability and help in monitoring the healthcare sector's integration and its effects on Medicare services. Proponents argue that this measure will provide essential information to ensure fair practices in the healthcare market.

Contention

Despite its potential benefits, the bill faces opposition from various stakeholders concerned about the increased regulatory burden on healthcare providers and pharmacies. Critics argue that the additional reporting requirements could disproportionally affect smaller providers and lead to reduced access in underserved areas. Additionally, there are concerns regarding the potential for misuse of the disclosed ownership information, which some fear could lead to competitive disadvantages and complexities in compliance across different states.

Companion Bills

US HB4822

Related Health Care Price Transparency Act of 2023

US HB5378

Related Lower Costs, More Transparency Act

Similar Bills

US SB113

Prescription Pricing for the People Act of 2023

US HB5378

Lower Costs, More Transparency Act

US HB3561

PATIENT Act of 2023 Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023

US HB2880

Protecting Patients Against PBM Abuses Act

US HB3285

Fairness for Patient Medications Act

US SB1339

Pharmacy Benefit Manager Reform Act

US HB4507

Transparency in Coverage Act

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.